InsiderTrades

Form 4 for RIGL RIGEL PHARMACEUTICALS INC

Accepted 2026-06-03 18:03:50 ET · period of report 2026-06-01 · accession 0000905148-26-002811 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-06-03 18:03 2026-06-01 RIGL Schorno Dean L EVP, CFO M - OptEx $14.83 +3,381 79.7K +4% +$50.1K
D 2026-06-03 18:03 2026-06-01 RIGL Schorno Dean L EVP, CFO F - Tax $29.86 -928 78.8K -1% -$27.7K
DM 2026-06-03 18:03 2026-06-01 RIGL Schorno Dean L EVP, CFO M - OptEx $0.00 -3,381 13.5K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-01 M A 1,200 $18.70 77,537 D — —
2 Common Common Stock 2026-06-01 M A 2,181 $12.70 79,718 D — — (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
3 Common Common Stock 2026-06-01 F D 928 $29.86 78,790 D — —
4 Derivative Employee Stock Option (right to buy) 2026-06-01 M D 1,200 $0.00 9,632 D $18.70 · — to 2033-01-26 1,200 Common Stock (F2) The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period.
5 Derivative Employee Stock Option (right to buy) 2026-06-01 M D 2,181 $0.00 13,518 D $12.70 · — to 2034-01-23 2,181 Common Stock (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F3) The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.